More precisely, the Omicron. You might be wondering why governments have gotten so aggressive lately. Reality is, this next wave will be the worst one yet. I’m going to tell you what you must do now in our latest edition of Radio Free Wall Street.
Continue reading “‘Significant increase’ in protection vs Omicron from mRNA boosters, study says”
BERLIN, Dec 22 (Reuters) – German Health Minister Karl Lauterbach said on Wednesday that a fourth vaccination will be necessary in the fight against the coronavirus pandemic due to the more contagious Omicron variant. He said that Germany has ordered 80 million doses of a vaccine made by Biontech specifically targeting Omicron and should arrive in April or May. Germany has also ordered four million doses of the newly approved vaccine Novavax – seen as more acceptable to vaccine sceptics – and 11 million doses of the new Valneva shot, which is waiting for marketing authorisation, Lauterbach said. The Novavax shots will arrive in the country in January, Lauterbach told a news conference. “An offensive booster campaign is our most important building block in the fight against Omicron,” the health minister said. Lauterbach threw his support behind a general vaccine mandate, saying that without one, it would not be possible to manage coming waves of infection over the long term. According to Lothar Wieler, president of Germany’s Robert Koch Institute (RKI) for infectious diseases, Omicron will be responsible for most coronavirus infections in Germany within three weeks. “Christmas should not become the spark that starts the Omicron blaze,” RKI chief Lothar Wieler told the same news conference, adding people should limit contacts to an absolute minimum. (Reporting by Zuzanna Szymanska and Miranda Murray Editing by Madeline Chambers.
he Omicron coronavirus variant seems to be causing milder COVID-19 symptoms compared to the Delta strain, according to conclusions set to be published by British government scientists. People living in the United Kingdom are less likely to become ill, Politico reported on Wednesday citing the study, noting high vaccination percentage as one of the main reasons driving high protection against COVID-19. Furthermore, the research is set to show that people who have been vaccinated with a booster dose have a significantly reduced chance of ending up in a hospital due to COVID-19. The report comes as the UK registers more than 90,000 new infections a day over the past week – the highest number since the start of the pandemic. Continue reading “Omicron milder than Delta in UK – report…… Another study finds Omicron MAY NOT be milder than Delta: UK Study”
Continue reading “Home Test Kits In Stock For Immediate Shipment”
The coronavirus pandemic still poses a threat, and will continue to do so, but the medical field and infectious disease experts have learned plenty about the virus and its spread. Tools such as safe vaccines and masking options offer individual protection. That means sports leagues will not shut down like they did 20 months ago. But with each passing day, it seems another sport or league is once again being affected by this pandemic, with postponements and infections. For example, 51 NFL players went on the COVID-19 reserve list Monday, including Kansas City Chiefs star Travis Kelce.
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., December 3, 2021. REUTERS/Brendan McDermid
Dec 20 (Reuters) – Wall Street’s main indexes opened lower on Monday, dragged by concerns about the impact of tighter COVID-19 curbs on the global economy, and a potentially devastating setback to President Joe Biden’s investment bill. The Dow Jones Industrial Average (.DJI) fell 143.32 points, or 0.41%, at the open to 35,222.12. The S&P 500 (.SPX) opened lower by 32.74 points, or 0.71%, at 4,587.90, while the Nasdaq Composite (.IXIC) dropped 236.68 points, or 1.56%, to 14,933.00 at the opening bell.
The other shots — including those from AstraZeneca, Johnson & Johnson and vaccines manufactured in China and Russia — do little to nothing to stop the spread of omicron, early research shows.
Continue reading “Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron”